U S Global Investors Inc. purchased a new stake in shares of Humana Inc (NYSE:HUM) in the third quarter, according to its most recent disclosure with the SEC. The firm purchased 2,200 shares of the insurance provider’s stock, valued at approximately $536,000.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in HUM. Janus Henderson Group PLC grew its holdings in Humana by 7,848.8% during the 2nd quarter. Janus Henderson Group PLC now owns 1,567,587 shares of the insurance provider’s stock valued at $377,192,000 after purchasing an additional 1,547,866 shares in the last quarter. FMR LLC grew its holdings in Humana by 29.3% during the 2nd quarter. FMR LLC now owns 6,530,063 shares of the insurance provider’s stock worth $1,571,264,000 after acquiring an additional 1,479,210 shares in the last quarter. Koch Industries Inc. acquired a new position in Humana during the 2nd quarter worth $404,000. TIAA CREF Investment Management LLC grew its holdings in Humana by 39.7% during the 2nd quarter. TIAA CREF Investment Management LLC now owns 1,358,617 shares of the insurance provider’s stock worth $326,910,000 after acquiring an additional 386,162 shares in the last quarter. Finally, Ameriprise Financial Inc. grew its holdings in Humana by 39.8% during the 2nd quarter. Ameriprise Financial Inc. now owns 1,322,413 shares of the insurance provider’s stock worth $318,216,000 after acquiring an additional 376,177 shares in the last quarter. 94.19% of the stock is owned by institutional investors and hedge funds.
Several research analysts have weighed in on HUM shares. BMO Capital Markets raised their price objective on shares of Humana from $290.00 to $300.00 and gave the stock an “outperform” rating in a report on Friday, November 10th. ValuEngine raised shares of Humana from a “hold” rating to a “buy” rating in a report on Friday, September 1st. Royal Bank Of Canada reissued a “sector perform” rating and set a $242.00 price objective (down from $245.00) on shares of Humana in a report on Thursday, November 9th. Credit Suisse Group decreased their price objective on shares of Humana from $256.00 to $246.00 and set a “neutral” rating for the company in a report on Friday, November 10th. Finally, Zacks Investment Research lowered shares of Humana from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 17th. Twelve analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. The stock has an average rating of “Hold” and an average price target of $255.80.
Humana Inc (NYSE:HUM) traded up $2.59 during mid-day trading on Monday, hitting $256.49. 985,100 shares of the company’s stock were exchanged, compared to its average volume of 1,380,953. Humana Inc has a one year low of $186.25 and a one year high of $264.56. The company has a market cap of $36,642.18, a P/E ratio of 21.89, a price-to-earnings-growth ratio of 1.76 and a beta of 0.88. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.61 and a quick ratio of 1.61.
Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, November 8th. The insurance provider reported $3.39 EPS for the quarter, topping analysts’ consensus estimates of $3.27 by $0.12. Humana had a net margin of 3.49% and a return on equity of 15.99%. The company had revenue of $13.28 billion for the quarter, compared to the consensus estimate of $13.41 billion. During the same period in the previous year, the firm earned $3.18 EPS. Humana’s revenue was down 3.0% on a year-over-year basis. sell-side analysts anticipate that Humana Inc will post 11.63 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Friday, January 26th. Shareholders of record on Friday, December 29th will be given a dividend of $0.40 per share. The ex-dividend date of this dividend is Thursday, December 28th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.62%. Humana’s dividend payout ratio (DPR) is 12.59%.
COPYRIGHT VIOLATION NOTICE: This news story was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this news story on another domain, it was illegally copied and reposted in violation of US and international copyright & trademark legislation. The legal version of this news story can be viewed at https://www.dispatchtribunal.com/2017/12/11/u-s-global-investors-inc-takes-position-in-humana-inc-hum.html.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).
Receive News & Ratings for Humana Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc and related companies with MarketBeat.com's FREE daily email newsletter.